Wordt geladen...

Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients

This case report series describes 3 cases of cisatracurium besylate associated phlebitis after an infusion period of 14–20 hours. No similar cases have been reported in the literature. Association of phlebitis with another neuromuscular blocking agent, atracurium, has been described in the literatur...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMJ Case Rep
Hoofdauteurs: Meeder, Annelijn M, van der Steen, Marijke S, Rozendaal, Annemieke, van Zanten, Arthur R H
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BMJ Publishing Group 2016
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5073701/
https://ncbi.nlm.nih.gov/pubmed/27698008
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2016-216448
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!